CPUH VS DNAD Stock Comparison

PerformanceTechnicalsProfitVolatility
PerformanceTechnicalsProfitVolatility

Performance

CPUH
100/100

CPUH returned 8.12% in the last 12 months. Based on SPY's performance of -3.18%, its performance is above average giving it a score of 100 of 100.

DNAD
100/100

DNAD returned 6.59% in the last 12 months. Based on SPY's performance of -4.12%, its performance is above average giving it a score of 100 of 100.

Technicals

CPUH
57/100

CPUH receives a 57 of 100 based on 14 indicators. 7 are bullish, 5 are bearish.

DNAD
93/100

DNAD receives a 92 of 100 based on 14 indicators. 12 are bullish, 0 are bearish.

Profit

CPUH
53/100

Out of the last 10 quarters, CPUH has had 6 profitable quarters and has increased their profits year over year on 2 of them.

DNAD
31/100

Out of the last 8 quarters, DNAD has had 4 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

CPUH
62/100

CPUH has had a higher than average amount of volatility over the last 12 months giving it a score of 62 of 100.

DNAD
43/100

DNAD has had a lower than average amount of volatility over the last 12 months giving it a score of 42 of 100.

All score calculations are broken down here to help you make more informed investing decisions

Compute Health Acquisition Corp. Summary

New York Stock Exchange / CPUH
Financial Services
Shell Companies
Compute Health Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Compute Health Acquisition Corp. was incorporated in 2020 and is based in Wilmington, Delaware.

Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares Summary

Nasdaq / DNAD
Financial Services
Shell Companies
Social Capital Suvretta Holdings Corp. IV does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.